China Biologic Products Holdings, Inc. adopted resolutions on August 3, 2018 to terminate, with cause, the employment of Mr. David (Xiaoying) Gao as the president and chief executive officer of the company pursuant to the employment agreement between the company and Mr. Gao. The Board previously passed resolutions to remove Mr. Gao from the chairman and chief executive officer positions and from the Board. Upon further review of the facts and circumstances, the Board determined that the termination of his employment shall be for cause.